Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

[1]  M. Danson,et al.  Citrate synthase. , 2020, Current topics in cellular regulation.

[2]  Sang-Nae Cho,et al.  Linezolid for XDR-TB--Final Study Outcomes. , 2015, The New England journal of medicine.

[3]  S. Burdette,et al.  Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Ruedi Aebersold,et al.  The complete structure of the 55S mammalian mitochondrial ribosome , 2015, Science.

[5]  M. Butt,et al.  Lack of Neuropathological Changes in Rats Administered Tedizolid Phosphate for Nine Months , 2014, Antimicrobial Agents and Chemotherapy.

[6]  P. Tulkens,et al.  Nonclinical and Pharmacokinetic Assessments To Evaluate the Potential of Tedizolid and Linezolid To Affect Mitochondrial Function , 2014, Antimicrobial Agents and Chemotherapy.

[7]  J. Gu,et al.  Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China , 2016, European Respiratory Journal.

[8]  J. Herrero,et al.  Linezolid-Induced Lactic Acidosis in Two Liver Transplant Patients with the Mitochondrial DNA A2706G Polymorphism , 2014, Antimicrobial Agents and Chemotherapy.

[9]  Tianlin Wang,et al.  Effect of linezolid on hematological and oxidative parameters in rats , 2014, The Journal of Antibiotics.

[10]  Ruedi Aebersold,et al.  Architecture of the large subunit of the mammalian mitochondrial ribosome , 2013, Nature.

[11]  E. Clementi,et al.  Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. , 2013, International journal of antimicrobial agents.

[12]  D. Follmann,et al.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis. , 2012, The New England journal of medicine.

[13]  F. Pea,et al.  Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. , 2012, The Journal of antimicrobial chemotherapy.

[14]  T. Shim,et al.  Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. , 2012, The Journal of antimicrobial chemotherapy.

[15]  T. Shim,et al.  Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis , 2012, European Respiratory Journal.

[16]  Á. Soriano,et al.  Usefulness of monitoring linezolid trough serum concentration in prolonged treatments. , 2011, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[17]  P. Viale,et al.  Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis , 2010, Antimicrobial Agents and Chemotherapy.

[18]  M. Janech,et al.  A case of lactic acidosis induced by linezolid , 2010, Nature Reviews Nephrology.

[19]  P. Polgreen,et al.  Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. , 2008, Diagnostic microbiology and infectious disease.

[20]  Deping Wang,et al.  Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. , 2008, Journal of medicinal chemistry.

[21]  Brian T. Tsuji,et al.  Linezolid‐Associated Peripheral and Optic Neuropathy, Lactic Acidosis, and Serotonin Syndrome , 2007, Pharmacotherapy.

[22]  A. Mankin,et al.  The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. , 2007, Molecular cell.

[23]  M. Hirano,et al.  Severe Lactic Acidosis Associated with Linezolid Use in a Patient with the Mitochondrial DNA A2706G Polymorphism , 2007, Pharmacotherapy.

[24]  F. Villarroya,et al.  Reversible Inhibition of Mitochondrial Protein Synthesis during Linezolid-Related Hyperlactatemia , 2006, Antimicrobial Agents and Chemotherapy.

[25]  A. T. Bentley,et al.  Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones , 2006, Antimicrobial Agents and Chemotherapy.

[26]  L. Van Haute,et al.  Linezolid-induced inhibition of mitochondrial protein synthesis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Ò. Miró,et al.  Mitochondrial toxicity associated with linezolid. , 2005, The New England journal of medicine.

[28]  J. Brieland,et al.  Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis , 2005, Antimicrobial Agents and Chemotherapy.

[29]  R. Nelson,et al.  Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  J. McArthur,et al.  The reliability and validity of the subjective peripheral neuropathy screen. , 1998, The Journal of the Association of Nurses in AIDS Care : JANAC.

[31]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[32]  L. Sagan.  On the origin of mitosing cells , 1967, Journal of theoretical biology.

[33]  T. Work,et al.  Biogenesis of Mitochondria , 1966, Nature.

[34]  D. C. HARRISON,et al.  Cytochrome Oxidase , 1938, Nature.

[35]  M. Bolhuis.  Linezolid in multidrug-resistant tuberculosis , 2015 .

[36]  A. Soriano,et al.  Utilidad de monitorizar la concentración sérica en el valle de linezolid en pacientes que reciben tratamientos prolongados , 2011 .

[37]  P. Srere,et al.  [1] Citrate synthase. [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)] , 1969 .